222 related articles for article (PubMed ID: 21795328)
1. Creation of a recombinant Rift Valley fever virus with a two-segmented genome.
Brennan B; Welch SR; McLees A; Elliott RM
J Virol; 2011 Oct; 85(19):10310-8. PubMed ID: 21795328
[TBL] [Abstract][Full Text] [Related]
2. Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.
Wichgers Schreur PJ; Oreshkova N; Moormann RJ; Kortekaas J
J Virol; 2014 Sep; 88(18):10883-93. PubMed ID: 25008937
[TBL] [Abstract][Full Text] [Related]
3. The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging.
Brennan B; Welch SR; Elliott RM
PLoS Pathog; 2014 Feb; 10(2):e1003922. PubMed ID: 24550727
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.
Tercero B; Narayanan K; Terasaki K; Makino S
J Virol; 2021 Jun; 95(14):e0042921. PubMed ID: 33952635
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a Candidate Live Attenuated Vaccine for Rift Valley Fever Virus with a Two-Segmented Genome.
Ayers VB; Huang YS; Dunlop JI; Kohl A; Brennan B; Higgs S; Vanlandingham DL
Viral Immunol; 2023 Jan; 36(1):33-40. PubMed ID: 36399689
[TBL] [Abstract][Full Text] [Related]
6. The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.
Nishiyama S; Lokugamage N; Ikegami T
J Virol; 2016 Jan; 90(7):3735-44. PubMed ID: 26819307
[TBL] [Abstract][Full Text] [Related]
7. Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system.
Ikegami T; Peters CJ; Makino S
J Virol; 2005 May; 79(9):5606-15. PubMed ID: 15827175
[TBL] [Abstract][Full Text] [Related]
8. Creation of a nonspreading Rift Valley fever virus.
Kortekaas J; Oreshkova N; Cobos-Jiménez V; Vloet RP; Potgieter CA; Moormann RJ
J Virol; 2011 Dec; 85(23):12622-30. PubMed ID: 21957302
[TBL] [Abstract][Full Text] [Related]
9. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
[TBL] [Abstract][Full Text] [Related]
10. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
[TBL] [Abstract][Full Text] [Related]
11. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
Nishiyama S; Slack OA; Lokugamage N; Hill TE; Juelich TL; Zhang L; Smith JK; Perez D; Gong B; Freiberg AN; Ikegami T
Virulence; 2016 Nov; 7(8):871-881. PubMed ID: 27248570
[TBL] [Abstract][Full Text] [Related]
13. Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection.
Crabtree MB; Kent Crockett RJ; Bird BH; Nichol ST; Erickson BR; Biggerstaff BJ; Horiuchi K; Miller BR
PLoS Negl Trop Dis; 2012; 6(5):e1639. PubMed ID: 22563517
[TBL] [Abstract][Full Text] [Related]
14. Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals.
Bird BH; Albariño CG; Hartman AL; Erickson BR; Ksiazek TG; Nichol ST
J Virol; 2008 Mar; 82(6):2681-91. PubMed ID: 18199647
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic insight into the efficient packaging of antigenomic S RNA into Rift Valley fever virus particles.
Tercero B; Terasaki K; Narayanan K; Makino S
Front Cell Infect Microbiol; 2023; 13():1132757. PubMed ID: 36875526
[TBL] [Abstract][Full Text] [Related]
16. [Rift Valley fever virus].
Ikegami T; Makino S
Uirusu; 2004 Dec; 54(2):229-35. PubMed ID: 15745161
[TBL] [Abstract][Full Text] [Related]
17. Host entry factors of Rift Valley Fever Virus infection.
Ganaie SS; Leung DW; Hartman AL; Amarasinghe GK
Adv Virus Res; 2023; 117():121-136. PubMed ID: 37832991
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus.
Lihoradova OA; Indran SV; Kalveram B; Lokugamage N; Head JA; Gong B; Tigabu B; Juelich TL; Freiberg AN; Ikegami T
PLoS Negl Trop Dis; 2013; 7(4):e2181. PubMed ID: 23638202
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Rift Valley fever virus transcriptional terminations.
Ikegami T; Won S; Peters CJ; Makino S
J Virol; 2007 Aug; 81(16):8421-38. PubMed ID: 17537856
[TBL] [Abstract][Full Text] [Related]
20. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.
Ikegami T; Won S; Peters CJ; Makino S
J Virol; 2006 Mar; 80(6):2933-40. PubMed ID: 16501102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
